Summary of Patchouli
Primary Information, Benefits, Effects, and Important Facts
Pogostemon cablin, also known as patchouli, is an herb used in aromatherapy, perfumes, and other fragrances.
Patchouli is often used to induce relaxation, but studies have found this effect to be unreliable. When it does work, patchouli supplementation reduces central nervous system activity.
Preliminary evidence suggests patchouli can alleviate influenza. It has a moderate effect on most strains of flu, and a powerful effect on the H1N1 strain. Animal evidence suggests patchouli supplementation may also have an anti-depressant effect.
The main bioactive of patchouli is called patchouli alcohol. It can be used to synthesize Taxol, an anti-cancer medicine.
Though patchouli may be an effective anti-flu herb that makes it easier to relax, much more research is needed to confirm these effects.
How to Take Patchouli
Recommended dosage, active amounts, other details
The standard dose for patchouli supplementation is based off of animal doses.
Approximately 40mg/kg of bodyweight of patchouli, given to rats, is associated with anti-depressant effects. This translates to the following human dosages:
• 440mg for a 150lb person
• 580mg for a 200lb person
• 730mg for a 250lb person
A dose of 40-80mg/kg of bodyweight, given to mice, is associated with an anti-flu effect. The estimated human dose equivalent is 3.2-6.4mg/kg of bodyweight.
Human Effect Matrix
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what effects patchouli has on your body, and how strong these effects are.
|Grade||Level of Evidence [show legend]|
|Robust research conducted with repeated double-blind clinical trials|
|Multiple studies where at least two are double-blind and placebo controlled|
|Single double-blind study or multiple cohort studies|
|Uncontrolled or observational studies only|
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
|Minor||- See study|
Studies Excluded from Consideration
Scientific Research on Patchouli
Click on any below to expand the corresponding section. Click on to collapse it.
Pogostemon cablin (of the family Lamiaceae) is a herb commonly known as 'Pathcouli' and beyond its wide-spread usage as an aromatic and cosmetic it appears to have some medicinal usage in Japanese (Kampo) medicine with the name Kakko for the purposes of virology and some digestive aid usages. Moderan day usages is mostly as a substrate for cosmeceutical production of perfumes and fragrances.
Historical usage for mostly being a pleasant aroma and warding off insects, but also appears to have some anti-viral usage in traditional medicine
Compounds known to be in the volatile oil fragment include
2-(1,3-dihydroxy-but-2-enylidene)-6-methyl-3-oxo-heptanoic acid (DHEMH)
Valencene, Elemol, and Farnesol
Eicosene at 5.27%
Napthoquinone at 2.45%
Patchouli alcohol (a molecule within the essential oil portion) is by far the most prominent molecule consisting of about one third of the essential oil; other molecules in relatively higher levels in Patchouli are the Guainene class and the Patchouline class
Although Patchouli alcohol was named after Pogostemon cablin where it was first detected, it can be found in the rhizome of the plant Valeriana wallichii known as 'Indian Valerian' (not to be confused with Valerian officinalis), particularly in a Valeriana wallichii Patchouli Alcohol Chemotype. This plant has a highly variable content of Patchouli Alcohol at 13.4-66.7%.
Additionally, it should be noted that other herbs in the same family as Patchouli (Pogostemon) such as Pogostemon heyneanus have different phytochemical profiles in the essential oil; species may not be easily interchangeable.
Indian Valerian is also a good source of the bioactive thought to be unique to Patchouli
Patchouli oil (injections) has been found to not have a significant influence on a passive avoidance response in mice; this study also confirmed the inefficacy of Clary Sage while noting CNS stimulation from peppermint and chamomile.
In opposition of these results, inhalation of Patchouli oil (2% oil solution, with 20µL put on a cotton ball and inhaled for 3-7 minutes) in otherwise healthy females resulted in a reduction in CNS activity as assessed by systolic blood pressure amplitude (SBP-LF amplitude) over 5s intervals of measurement; the degree of CNS reduction relative to control was approximately 40%.
Some studies conducted in the Patchouli alcohol chemotype of Valeriana wallichii note that an extract of the essential oil (70% Patchouli alcohol) fed to rats at 40mg/kg acutely (10-20mg/kg being ineffective) noted a decrease in immonility time by 32.7% in a Forced Swim Test while the active control of Imipramine (10mg/kg) was not significantly different at 36.2% (after 14 days of treatment, Imipramine eventually reached 89.4%) This study noted that the extract increased norephedrine (20-23% at 20-40mg/kg) and Dopamine (15% at 40mg/kg) without influencing serotonin. These anti-depressant actions were later found to be inhibited with L-Arginine and Viagra (positive influencers of nitric oxide) and potentiated by both Methylene Blue and L-NAME suggesting that the nitric oxide pathway negatively regulates the observed anti-depressant effects.
Valeriana wallichii Patchouli alcohol chemotype has limited evidence for anti-depressive effects, which may apply to Patchouli if the main bioactive underlying these effects is Patchouli alcohol (insofar not estaglished)
Patchouli alcohol has shown anti-inflammatory activity in activated macrophages by suppressing the translocation of NF-kB, thought to be secondary to reducing ERK1/2 (one of three MAPKs) phosphorylation. Antiinflammatory effects have been noted with Patchouli alcohol elsewhere in LPS-activated macrophages where 10-40μM noted that iNOS induction, COX-2 mRNA, and PGE2 content were concentration-dependently inhibited. Cytokines such as IL-1β, IL-6, and TNF-α were all similarly reduced to the same degree, although no parameter exceeding 50% reduction (between LPS control and non-activated control)
Has general anti-inflammatory effects in vitro, although it does not appear to be that potent overall in the classical macrophage activation assay
Combination therapy with Curcuma wenyujin, Crysthanthemum, and Patchouli oil (named CPZ from Traditional Chinese Medicine; 1:3:3 ratio) at 85-170mg/kg in mice noted that the reduction of DMB-induced ear vasodilation (indicative of inflammation) was reduced to a comparable level as the active control of 25mg/kg Indomethacin while the lower doses (42.5-85mg/kg) were comparable to Indomethacin in reducing carrageenan-induced paw edema; the higher doses were comparable for only 1-2 hours before losing efficacy.
Combination therapy involving Patchouli has been noted to have anti-inflammatory properties
In regards to the flu (Influenza viral strain A/PR/8/34; H1N1), a methanolic extract appears to have potent anti-viral activity by inhibiting neuraminidase by 99.8% at 10μg/mL and preserving 97.5% of infected cells without direct cytotoxicity unto the cells at the tested concentration. This was attributed to Patchouli alcohol (molecule), which reduced viral plaque formation by 75% at 2μg/mL, and was determined to have an IC50 of 2.635-2.875μM (535-639ng/mL). This study later noted that the application of Patchouli alcohol on two viral H3N2 strains and failed to replicate the nanomolar potency, with no detectable activity up to 10μg/mL on A/Guizhou/54/89 and an IC50 of 40.82μM on B/Ibaraki/2/85.
Pathcouli alcohol itself failed to inhibit neuraminidase on these two tested strains while interfering with neuraminidase function in another study assessing H2N2 strains with an IC50 of 4.03+/-0.23, significantly weaker than the active control of Oseltamivir (Tamiflu).
Appears to have efficacy in vitro for inhibiting viral replication of the flu (Influenza) with quite a fair bit of potency on H1N1 but only moderate levels of potency on other viral strains
One study has been conducted in mice injected with the H1N1 virus, where 20-80mg/kg of isolated Patchouli oil was able as effective as 70mg/kg Ribavirin in preserving the life of mice given a lethal dose and with 80mg/kg reducing the viral load in lung tissue to a similar level as Ribavirin.
The amount of detectable Immunoglobulins specific for influenza (A, G, and M) and the cytokines IL-10 and IFN-γ in the serum of mice fed Pathouli alcohol was also significantly enhanced in a dose-dependent manner, with lung concentrations for Immunoglobulin G (but not A nor M) and both cytokines increasing at 40-80mg/kg of Pathouli Oil. This was met with significant enhancement of the percentage of T-cells expressing CD3+ or CD4+ receptors, with a suppression of CD8+ receptors (no dose dependence) and TNF-α appeared to be suppressed.
At least one mouse study has confirmed in vivo anti-influenza effects with Patchouli Alcohol with 80mg/kg (human estimated equivalent of 6.4mg/kg) being slightly lesser or equally effective as Ribavirin
One study that used Patchouli as a 'relaxing' aroma (as well as both Lavender and Rose Oil) noted that participants blinded the the purpose of the study and exposured to the aroma of the three aforementioned herbs failed to significantly influence the immune system when measure white blood cell parameters and count.
TNF-α was significantly reduced in females only (no significant effect on the whole group) as was Plasminogen activator inhibitor 1 (PAI-1).
The aroma of Pathcouli has only been tested once, but failed to significantly influence immunity
- Trellakis S, et al. Subconscious olfactory influences of stimulant and relaxant odors on immune function. Eur Arch Otorhinolaryngol. (2012)
- Ichikawa K, Kinoshita T, Sankawa U. The screening of Chinese crude drugs for Ca2+ antagonist activity: identification of active principles from the aerial part of Pogostemon cablin and the fruits of Prunus mume. Chem Pharm Bull (Tokyo). (1989)
- Kiyohara H, et al. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J Nat Med. (2012)
- Bhatia SP, Letizia CS, Api AM. Fragrance material review on patchouli alcohol. Food Chem Toxicol. (2008)
- Zhang QH, Schneidmiller RG, Hoover DR. Essential oils and their compositions as spatial repellents for pestiferous social wasps. Pest Manag Sci. (2012)
- Wu HQ, et al. Acaricidal activity of DHEMH, derived from patchouli oil, against house dust mite, Dermatophagoides farinae. Chem Pharm Bull (Tokyo). (2012)
- Zhu BC, et al. Toxicity and repellency of patchouli oil and patchouli alcohol against Formosan subterranean termites Coptotermes formosanus Shiraki (Isoptera: Rhinotermitidae). J Agric Food Chem. (2003)
- Trongtokit Y, et al. Comparative repellency of 38 essential oils against mosquito bites. Phytother Res. (2005)
- Tong J, et al. Selective separation of patchouli alcohol from the essential oil of Cablin potchouli by inclusion crystalline method. Nat Prod Res. (2013)
- Hussin N, et al. Quantitative and physical evaluation of patchouli essential oils obtained from different sources of Pogostemon cablin. Nat Prod Commun. (2012)
- Manoj G, Manohar SH, Murthy HN. Chemical constituents, antioxidant and antimocrobial activity of essential oil of Pogostemon paniculatus (Willd.). Nat Prod Res. (2012)
- Deguerry F, et al. The diverse sesquiterpene profile of patchouli, Pogostemon cablin, is correlated with a limited number of sesquiterpene synthases. Arch Biochem Biophys. (2006)
- Hu LF, et al. GC-MS fingerprint of Pogostemon cablin in China. J Pharm Biomed Anal. (2006)
- Yang Y, et al. Anti-emetic principles of Pogostemon cablin (Blanco) Benth. Phytomedicine. (1999)
- Sah SP, Mathela CS, Chopra K. Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: Behavioural and biochemical evidence. J Ethnopharmacol. (2011)
- Verma RS, et al. Chemical diversity in the essential oil of Indian valerian (Valeriana jatamansi Jones). Chem Biodivers. (2011)
- Murugan R, et al. Volatile oil composition of Pogostemon heyneanus and comparison of its composition with patchouli oil. Nat Prod Commun. (2010)
- Umezu T. Evaluation of the effects of plant-derived essential oils on central nervous system function using discrete shuttle-type conditioned avoidance response in mice. Phytother Res. (2012)
- Haze S, Sakai K, Gozu Y. Effects of fragrance inhalation on sympathetic activity in normal adults. Jpn J Pharmacol. (2002)
- Sah SP, Mathela CS, Chopra K. Involvement of nitric oxide (NO) signalling pathway in the antidepressant activity of essential oil of Valeriana wallichii Patchouli alcohol chemotype. Phytomedicine. (2011)
- Jeong JB, Shin YK, Lee SH. Anti-inflammatory activity of patchouli alcohol in RAW264.7 and HT-29 cells. Food Chem Toxicol. (2013)
- Xian YF, et al. Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Exp Ther Med. (2011)
- Su JY, et al. Experimental study on anti-inflammatory activity of a TCM recipe consisting of the supercritical fluid CO2 extract of Chrysanthemum indicum, Patchouli Oil and Zedoary Turmeric Oil in vivo. J Ethnopharmacol. (2012)
- Wu H, et al. Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus. Molecules. (2011)
- Li YC, et al. Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. Int Immunopharmacol. (2012)